title: [Optimization of parodontitis treatment of patients with tuberculosis].
abstract: For the purpose to determine the clinic-pathogenetic efficacy of Cycloferon liniment in the combined therapy of parodontitis of patients with focal tuberculosis medical examination and treatment of 40 patients is carried out. It is established, that use of liniment Cycloferon in the combined treatment of patients with focal tuberculosis allows to accelerate process of normalization of lipid peroxidation parameters and antioxidant potential of blood, to decrease infection load (Herpes symplex virus I, Candida albicans, Staphylococcus aureus) in parodontal recess and evidence of local inflammation with reduction of activity of the tumours necrosis factor and interleukin 1beta, that provides acceleration of recuperation processes, lowering the frequency of parodontitis relapses.
authors.forename: E A
authors.initials: EA
authors.lastname: Aleksandrova
authors.forename: A V
authors.initials: AV
authors.lastname: Lepilin
authors.forename: N E
authors.initials: NE
authors.lastname: Kazimirova
authors.forename: A A
authors.initials: AA
authors.lastname: Shul'diakov
mesh_terms: D000166:Acridines / Q000627:therapeutic use*; D000328:Adult; D002176:Candida albicans / Q000302:isolation & purification; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D003587:Cytomegalovirus / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008038:Liniments; D008297:Male; D010510:Periodontal Diseases / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D018139:Simplexvirus / Q000302:isolation & purification; D014397:Tuberculosis, Pulmonary / Q000150:complications*; D055815:Young Adult
chemical_list: D000166:Acridines; D007369:Interferon Inducers; D008038:Liniments; C026430:10-carboxymethyl-9-acridanone